[...] Posted May 23, 2016 Share Posted May 23, 2016 From Australia. Answers the questions why no longterm studies. Professor Paul Myles, Director of Anaesthesia and Perioperative Medicine at the Alfred and Monash University, and Sophie Wallace, research manager at Alfred Health, discuss the need to streamline the reporting of serious adverse events in Phase IV clinical trials. With MJA news and online editor, Cate Swannell. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now